Lastly, our cell line model lacked expression of IL34, which is also a ligand for the receptor CSF1R. Future work should more broadly study the clinical relevance of CSF1R signaling, both as a predictor of poor outcomes (e.g., hearing loss, rapid tumor growth) as well as its potential targetability. This evidence concerns the gene IL34 and neoplasm.